MedElevator
Войти в исследования EBioMedicine · 2026
HIV-1 virome profiling using HIV-PULSE to guide therapeutic and curative interventions.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
De Braekeleer Sofie, Lambrechts Laurens, Termote Liesbet, Delporte Mareva, Mehta Kavita, Matzaraki Vasiliki, Blomme Evy E, Lemey Philippe, Vrancken Bram, Rokx Casper, Stalenhoef Janneke, Berrevoets Marvin A H, van der Ven Andre J, Gerlo Sarah, Rutsaert Sofie, Vandekerckhove Linos
Аннотация
BACKGROUND: The persistent HIV-1 reservoir remains a major barrier to curing HIV-1, underscoring the need for a detailed understanding of its composition to inform targeted interventions.
METHODS: Here, we apply the HIV Proviral Unique molecular identifier-mediated Long-read Sequencing (HIV-PULSE) assay to characterise the viral reservoir in 90 individuals on suppressive antiretroviral therapy. By generating near full-length proviral sequences, HIV-PULSE enables multiple layers of in silico analyses across the HIV-1 genome.
FINDINGS: These data support the construction of participant-specific HIV virome profiles, integrating assessments of proviral intactness, tropism, genetic diversity, archived drug resistance mutations and susceptibility to selected immune-based therapies (broadly neutralising antibodies and HIV-specific immune-mobilising monoclonal T cell receptor therapy IMC-M113V).
INTERPRETATION: Our findings demonstrate that HIV-PULSE provides a comprehensive platform for individualised reservoir profiling, advancing future treatment perspectives and efforts towards an HIV-1 cure.
FUNDING: This research is part of the 2000HIV study, supported by ViiV Healthcare.
METHODS: Here, we apply the HIV Proviral Unique molecular identifier-mediated Long-read Sequencing (HIV-PULSE) assay to characterise the viral reservoir in 90 individuals on suppressive antiretroviral therapy. By generating near full-length proviral sequences, HIV-PULSE enables multiple layers of in silico analyses across the HIV-1 genome.
FINDINGS: These data support the construction of participant-specific HIV virome profiles, integrating assessments of proviral intactness, tropism, genetic diversity, archived drug resistance mutations and susceptibility to selected immune-based therapies (broadly neutralising antibodies and HIV-specific immune-mobilising monoclonal T cell receptor therapy IMC-M113V).
INTERPRETATION: Our findings demonstrate that HIV-PULSE provides a comprehensive platform for individualised reservoir profiling, advancing future treatment perspectives and efforts towards an HIV-1 cure.
FUNDING: This research is part of the 2000HIV study, supported by ViiV Healthcare.